StockWatch
·
Pharmaceutical Preparations
Corporate GovernanceApr 30, 2026, 04:35 PM

SYBX Amends 10-K for Corporate Governance & Executive Comp

AI Summary

SYNLOGIC, INC. (SYBX) filed an amendment to its 10-K to include previously omitted Part III information, primarily focusing on Directors, Executive Officers, and Corporate Governance, as well as Executive Compensation. The amendment details the composition of the Board of Directors, their independence, and the roles and compensation of the executive officer, Mary Beth Dooley. It also notes that no cash bonuses or equity awards were granted in 2025 due to the discontinuation of a pivotal study and a significant workforce reduction.

Key Highlights

  • SYBX amended its 10-K to include omitted Part III information on corporate governance and executive compensation.
  • Board of Directors consists of four independent members: Peter Barrett (Chairman), James Flynn, Edward Mathers, and Richard P. Shea.
  • Mary Beth Dooley serves as Principal Executive Officer and Principal Financial Officer.
  • Mary Beth Dooley's total compensation for 2025 was $335,500.
  • Mary Beth Dooley's total compensation for 2024 was $486,490, including a $97,500 bonus.
  • No cash bonuses or equity awards were granted to named executive officers in 2025 due to the discontinuation of the Synpheny-3 study and workforce reduction.
  • As of March 31, 2026, the company had one full-time employee.
  • The company adopted a Clawback Policy on September 20, 2023, to comply with new SEC and Nasdaq rules.